Literature DB >> 29072042

Active exergames to improve cognitive functioning in neurological disabilities: a systematic review and meta-analysis.

Gioia Mura1, Mauro G Carta2, Federica Sancassiani2, Sergio Machado3,4,5, Luca Prosperini6,7.   

Abstract

INTRODUCTION: Exergames represent a way to perform physical activity through active video games, serving as potentially useful tool in the field of neurorehabilitation. However, little is known regarding the possible role of exergames in improving cognitive functions in persons suffering from neurological disabilities. EVIDENCE ACQUISITION: A search for relevant articles was carried out on PubMed/Medline, Scopus, PEDro, and Google Scholar. Only randomized controlled studies and non-randomized but controlled studies were retained. The following additional inclusion criteria were applied: studies focused on physical activity interventions carried out by means of exergames; populations targeted were affected by neurological disabilities; and reported results were related to cognitive outcomes. We calculated standardized mean differences (SMD) and pooled results using a random effects meta-analysis. EVIDENCE SYNTHESIS: Of 520 abstracts screened, thirteen studies met the criteria to be included yielding a total of 465 participants, 233 randomized to exergames, and 232 allocated to the alternative or no intervention. The included studies varied in terms of studied populations (e.g., multiple sclerosis, post-stroke hemiparesis, Parkinson's disease, dementia, dyslexia, Down syndrome), type and duration of interventions, and cognitive outcome measures. Exergames significantly improved executive functions (SMD=0.53, P=0.005; 8 studies, N.=380) and visuo-spatial perception (SMD=0.65, P<0.0001; 5 studies, N.=209) when compared to the alternative or no intervention. There were no significant differences for attention (SMD=0.57, P=0.07; 7 studies, N.=250) and global cognition (SMD=0.05, P=0.80; 6 studies, N.=161).
CONCLUSIONS: Exergames are a highly-flexible tool for rehabilitation of both cognitive and motor functions in adult populations suffering from various neurological disabilities and developmental neurological disorders. Additional high-quality clinical trials with larger samples and more specific cognitive outcomes are needed to corroborate these preliminary findings. CLINICAL REHABILITATION IMPACT: Exergames could be considered either as a supplemental treatment to conventional rehabilitation, or as strategy to extend benefits of conventional programs at home.

Entities:  

Mesh:

Year:  2017        PMID: 29072042     DOI: 10.23736/S1973-9087.17.04680-9

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  22 in total

Review 1.  Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines.

Authors:  Kirk I Erickson; Charles Hillman; Chelsea M Stillman; Rachel M Ballard; Bonny Bloodgood; David E Conroy; Richard Macko; David X Marquez; Steven J Petruzzello; Kenneth E Powell
Journal:  Med Sci Sports Exerc       Date:  2019-06       Impact factor: 5.411

2.  Video Games for the Treatment of Autism Spectrum Disorder: A Systematic Review.

Authors:  Laura Jiménez-Muñoz; Inmaculada Peñuelas-Calvo; Pilar Calvo-Rivera; Isaac Díaz-Oliván; Manon Moreno; Enrique Baca-García; Alejandro Porras-Segovia
Journal:  J Autism Dev Disord       Date:  2021-03-02

3.  Design and Evaluation of User-Centered Exergames for Patients With Multiple Sclerosis: Multilevel Usability and Feasibility Studies.

Authors:  Alexandra Schättin; Stephan Häfliger; Alain Meyer; Barbara Früh; Sonja Böckler; Yannic Hungerbühler; Eling D de Bruin; Sebastian Frese; Regula Steinlin Egli; Ulrich Götz; René Bauer; Anna Lisa Martin-Niedecken
Journal:  JMIR Serious Games       Date:  2021-05-07       Impact factor: 4.143

Review 4.  Physical Exercise For Parkinson's Disease: Clinical And Experimental Evidence.

Authors:  Alessandro Oliveira de Carvalho; Alberto Souza Sá Filho; Eric Murillo-Rodriguez; Nuno Barbosa Rocha; Mauro Giovanni Carta; Sergio Machado
Journal:  Clin Pract Epidemiol Ment Health       Date:  2018-03-30

5.  Recent advances in rehabilitation for Parkinson's Disease with Exergames: A Systematic Review.

Authors:  Augusto Garcia-Agundez; Ann-Kristin Folkerts; Robert Konrad; Polona Caserman; Thomas Tregel; Mareike Goosses; Stefan Göbel; Elke Kalbe
Journal:  J Neuroeng Rehabil       Date:  2019-01-29       Impact factor: 4.262

6.  Affective Game Planning for Health Applications: Quantitative Extension of Gerontoludic Design Based on the Appraisal Theory of Stress and Coping.

Authors:  Najmeh Khalili-Mahani; Bob De Schutter
Journal:  JMIR Serious Games       Date:  2019-06-06       Impact factor: 4.143

7.  Technology Integration Methods for Bi-directional Brain-computer Interfaces and XR-based Interventions.

Authors:  Kei Landin; Moaad Benjaber; Fawad Jamshed; Charlotte Stagg; Timothy Denison
Journal:  Conf Proc IEEE Int Conf Syst Man Cybern       Date:  2020-12-14

Review 8.  Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review.

Authors:  Marcello De Angelis; Luigi Lavorgna; Antonio Carotenuto; Martina Petruzzo; Roberta Lanzillo; Vincenzo Brescia Morra; Marcello Moccia
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

Review 9.  Home/community-based interventions to improve function in persons with mild cognitive impairment/early dementia.

Authors:  Emerald Jenkins; Binu Koirala; Tamar Rodney; Ji Won Lee; Valerie T Cotter; Sarah L Szanton; Janiece L Taylor
Journal:  Geriatr Nurs       Date:  2021-07-16       Impact factor: 2.525

10.  The Enhanced Interactive Physical and Cognitive Exercise System (iPACESTM v2.0): Pilot Clinical Trial of an In-Home iPad-Based Neuro-Exergame for Mild Cognitive Impairment (MCI).

Authors:  Kathryn Wall; Jessica Stark; Alexa Schillaci; Emilie T Saulnier; Elizabeth McLaren; Kristina Striegnitz; Brian D Cohen; Paul J Arciero; Arthur F Kramer; Cay Anderson-Hanley
Journal:  J Clin Med       Date:  2018-08-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.